Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caspase inhibitors - A chemist's perspective.

Piotr P. Graczyk1

  • 1Department of Medicinal Chemistry, EISAI London Research Laboratories University College London, Bernard Katz Building, London WC1E 6BT UK. Tel.: + 44 171 388 4746; Fax: + 44 171 413 1121;

Restorative Neurology and Neuroscience
|April 3, 2003
PubMed
Summary

New peptide-based caspase inhibitors show promise for treating neurodegenerative diseases. Prodrug strategies enhance cell permeability, potentially leading to novel neuroprotective drugs targeting apoptotic mechanisms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inapplicability of the Antiperiplanar Lone Pair Hypothesis to C-P Bond Breaking and Formation in Some S-C-P(+) Systems.

The Journal of organic chemistryยท1996
See all related articles

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Neurodegeneration is increasingly linked to apoptotic cell death mechanisms.
  • Caspases, enzymes activated during apoptosis, are potential therapeutic targets.
  • Existing caspase inhibitors face challenges like limited cell membrane permeability.

Purpose of the Study:

  • To explore novel peptide-based caspase inhibitors for neuroprotection.
  • To investigate the efficacy of new pharmaeophores conjugated to peptides.
  • To address cell permeability issues of peptide inhibitors using prodrug strategies.

Main Methods:

  • Synthesis of peptide conjugates with quinones, epoxyquinones, and epoxyquinols.
  • Assay of inhibitor activity against caspase-3.

Related Experiment Videos

  • Evaluation of neuroprotective effects on neuronal cells.
  • Development of double ester-type prodrugs for enhanced cell delivery.

    • Main Results:

    • Peptide conjugates demonstrated submicromolar activity against caspase-3.
    • Moderate neuroprotective effects were observed in neuronal cells.
    • Double ester-type prodrugs showed potential for improving cell membrane transport of peptide inhibitors.

    Conclusions:

    • Novel peptide-based caspase inhibitors exhibit therapeutic potential for neurodegenerative diseases.
    • Prodrug approaches offer a viable strategy to overcome cell permeability limitations.
    • Further development could lead to new neuroprotective agents targeting apoptosis.